← Back

Wire · regulatory

DIAGNOS Receives Saudi FDA Medical Device License for CARA System, Bringing AI ...

Published

13 August 2026

Topic

regulatory

Sectors

Digital Health

Geography

Saudi Arabia

Source

Read at investingnews.com

Verified

Fusion42 · 13 August 2026 · Fusion42 review

Diagnos Inc. received Medical Device Marketing Authorization from the Saudi Food and Drug Authority for its CARA System, an AI-assisted retinal image analysis device detecting Diabetic Retinopathy and Age-related Macular Degeneration. This approval opens access to a large market of over 5 million adults in Saudi Arabia needing regular screening for these conditions.

This Wire brief sits within Fusion42's coverage of Digital Health, and 3 sources have reported it.

◆ The Wire takeaway

You gain a new market unlocked by Saudi FDA approval of AI retinal screening tech; start building local healthcare partnerships now to reach millions needing diabetic eye care.

Coverage

3 sources · 13 Aug 2026

Related on Wire

Topics

Digital Healthmedical-devicesaudi-fdaai-healthtechretina-screeningdiabetic-retinopathy